Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
Alnylam Pharmaceuticals, Inc. · PHARMACEUTICAL PREPARATIONS · Now $301.98
+6.6% in 7d after detection
Post-detection moves
1h
—
1d
+2.8%
3d
+5.0%
7d
+6.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS